Acer Therapeutics Inc. (ACER) earnings
Quarterly and annual ACER reports and results, each read against the price at its own news timestamp. Back to the ACER overview →
2 measured ACER earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Acer Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q Acer Therapeutics Inc. For: Sep 30 | SEC filing · Form NT | +0.00% | +2.50% |
Keep exploring
More ACER: analyst actions → · SEC filings → · ACER overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OLYMPUS CORP S/ADR (OCPNY) | 39 | 0.00% | 47% |
| RYMAN HEALTHCARE UNSP/ADR (RYHTY) | 39 | 0.00% | 0% |
| Aeglea BioTherapeutics, Inc. (AGLE) | 38 | 0.00% | 22% |
| Bellicum Pharmaceuticals, Inc. (BLCM) | 38 | 0.00% | 29% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.